E-mail a copy of 'ZymoGenetics Rival Emerges, Omeros IPO Casts Shadow, Microsoft's HealthVault Seeks Users, & More Seattle Area Life Sciences News' to a friend
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.